Skip to main content
. 2014 Feb 19;22(11):1305–1313. doi: 10.1038/ejhg.2014.16

Table 1. BRCA1 and BRCA2 variations used for the NGS validation.

Patients Gene a Type site Description b Expected consequence c Detectable with Casava Detectable with NextGene Detectable with CNVseq
T1 BRCA1 LGR Del 1–24 c.1-?_5592+?del p.? NA NA Yes
T2 BRCA1 LGR Dup 5–7 c.135-?_441+?dup p.? NA NA Yes
T3 BRCA1 indel Ex 11 c.2612_2613insT p.Phe872Valfs*31 Yes Yes NA
T4 BRCA1 LGR Dup 13 c.4186-?_4357+?dup p.? NA NA Yes
T5 BRCA1 indel Ex 13 c.4282ins39 p.Ser1428* Yes Yes NA
T6 BRCA1 indel Ex 18 c.5077_5080delinsTTCATTCTGC p.Ala1693_Glu1694delinsPheIleLeuGln Yes Yes NA
T7 BRCA2 indel Ex 9 c.736_755del p.Phe246Glnfs*2 Yes Yes NA
T8 BRCA2 indel Ex 10 c.1231_1241delinsACAT p.Ile411Thrfs*17 Yes Yes NA
T9 BRCA2 SNV Ex 12 c.6848C>A p.Pro2283His Yes Yes NA
T10 BRCA2 indel Ex 14 c.7069_7070del p.Leu2357Valfs*2 Yes Yes NA
T11 BRCA2 indel Ex 23 c.9097dup p.Thr3033Asnfs*11 Yes Yes NA
T12 BRCA1 indel Ex 11 c.1175_1214del p.Leu392Glnfs*5 Yes Yes NA
T13 BRCA1 indel Ex 11 c.3481_3491del p.Glu1161Phefs*3 Yes Yes NA
T14 BRCA1 indel Ex 11 c.3947_3950delTCTT p.Phe1316* Yes Yes NA
T15 BRCA1 indel Int 20 c.5277+48_5277+59dup p.? No Yes NA
T16 BRCA1 indel Ex 11 c.3731_3738del p.His1244Argfs*8 Yes Yes NA
T17 BRCA2 indel Int 8 c.681+97_681+98delGT p.? Yes Yes NA
T17 BRCA1 indel Int 21 c.5332+182dup p.? Yes Yes NA
T18 BRCA1 indel Ex 6 c.282_288dup p.Thr97Alafs*2 Yes Yes NA
T19 BRCA1 indel Ex 11 c.2709_2710del p.Cys903* Yes Yes NA
T20 BRCA1 indel Ex 11 c.1016dup p.Val340Glyfs*6 Yes Yes NA
T21 BRCA1 indel Ex 11 c.3770_3771del p.Glu1257Glyfs*9 Yes Yes NA
T22 BRCA1 indel Ex 11 c.3541_3556del p.Val1181Leufs*24 Yes Yes NA
T23 BRCA1 indel Ex 14 c.4391_4393delinsTT p.Pro1464Leufs*2 Yes Yes NA
T24 BRCA1 indel Ex 11 c.2269del p.Val757Phefs*8 Yes Yes NA
T25 BRCA1 indel Ex 11 c.3839_3843delinsAGGC p.Ser1280* Yes Yes NA
T26 BRCA2 indel Ex 25 c.9435_9436del p.Ser3147Cysfs*2 Yes Yes NA
T27 BRCA2 indel Ex 16 c.7795_7797del p.Glu2599del Yes Yes NA
T28 BRCA2 SNV Ex 10 c.1395A>C p.= Yes Yes NA
T28 BRCA2 indel Ex 10 c.1389_1390del p.Val464Glyfs*3 Yes Yes NA
T29 BRCA2 indel Ex 18 c.8053del p.Thr2685Hisfs*9 Yes Yes NA
T30 BRCA2 indel Ex 10 c.1796_1800del p.Ser599* Yes Yes NA
T31 BRCA2 indel Ex 11 c.6408_6414del p.Asn2137Lysfs*29 Yes Yes NA
T32 BRCA2 indel Ex 8 c.635_636del p.Arg212Lysfs*2 Yes Yes NA
T33 BRCA2 indel Ex 11 c.6079dup p.Arg2027Lysfs*22 Yes Yes NA
T34 BRCA2 indel Ex 27 c.9699_9702del p.Cys3233Trpfs*15 Yes Yes NA
T35 BRCA2 indel Ex 9 c.755_758del p.Asp252Valfs*24 Yes Yes NA
T36 BRCA2 indel Ex 11 c.5810_5811del p.Ser1937Trpfs*7 Yes Yes NA
T37 BRCA2 indel Ex 22 c.8773_8780dup p.Arg2927Serfs*3 Yes Yes NA
T38 BRCA1 SNV Int 5 c.213-1G>A p.? Yes Yes NA
T39 BRCA1 SNV Ex 11 c.3979C>T p.Gln1327* Yes Yes NA
T40 BRCA2 SNV Int 6 c.516+2T>C p.? Yes Yes NA
T41 BRCA2 SNV Ex 13 c.7007G>A p.Arg2336His Yes Yes NA
T42 BRCA2 SNV Ex 12 c.6848C>A p.Pro2283His Yes Yes NA
T43 BRCA2 SNV Ex 15 c.7558C>T p.Arg2520* Yes Yes NA
T44 BRCA2 SNV Ex 21 c.8707G>T p.Glu2903* Yes Yes NA
T45 BRCA2 SNV Ex 3 c.273C>A p.Tyr91* Yes Yes NA
T46 BRCA1 LGR Del 1–2 c.-232-?_80+?del p.? NA NA Yes
T47 BRCA1 LGR Del 11–12 c.671-?_4185+?del p.? NA NA Yes
T48 BRCA1 LGR Del 3 c.81-?_134+?del p.? NA NA Yes
T49 BRCA1 LGR Del 8–13 c.442-?_4357+?del p.? Yes Yes NA
T49 BRCA2 indel Ex 11 c.5272_5274del p.Asn1758del Yes Yes NA
T50 BRCA1 LGR Del 3–16 c.81-?_4986+?del p.? NA NA Yes
T51 BRCA1 LGR Del 5–24 c.135-?_5592+?del p.? NA NA Yes
T52 BRCA1 LGR Del 17 c.4987-?_5074+?del p.? NA NA Yes
T53 BRCA1 LGR Dup 3–8 c.81-?_547+?dup p.? NA NA Yes
T54 BRCA1 LGR Del 22 c.5333-?_5406+?del p.? NA NA Yes
T55 BRCA1 LGR Del NBR2-2 c.-232-?_80+?del p.? NA NA Yes
T56 BRCA1 LGR Del 21 c.5278-?_5332+?del p.? NA NA Yes
T57 BRCA1 LGR Del 20 c.5194-?_5277+?del p.? NA NA Yes
T58 BRCA2 LGR Del 12–13 c.6842-?_7007+?del p.? NA NA Yes
T59 BRCA2 indel Ex 3 c.156_157insAlud p.? Yes No No

Abbreviations: LGR, large genomic rearrangement; NA, not applicable.

a

Nomenclature was numbered on the basis of the transcript NM_007294 for BRCA1 and NM_000059 for BRCA2.

b

Mutation nomenclature according to HGVS recommendations, nucleotide position was numbered with +1 corresponding to the A of the ATG of the translation initiation codon.

c

Expected consequence on the protein level.

d

Corresponding to the Portuguese founder mutation c.156_157insAP003441.3:g.105088_105370.